Totaligent, Inc. (OTCID: TGNT) (“Totaligent” or “the Company”), an emerging leader in specialized infrastructure platform for the blossoming biologics space and intelligent business marketing data, announces the successful closing of the previously announced Definitive Agreement with Ivan Klarich, founder of Aetherium Medical, for the strategic acqui-hire of the Aetherium Medical platform and team. The Aetherium platform serves as essential infrastructure connecting innovative biotechnology companies—particularly those advancing AI-enabled biologics and regenerative therapies—with global patients through ethical, efficient, and compliant medical-tourism channels in the Asia-Pacific region.
Read the full article: Totaligent Closes Strategic Acqui-Hire of Aetherium Medical Platform //
Source: https://www.globenewswire.com/news-release/2026/05/20/3298446/0/en/Totaligent-Closes-Strategic-Acqui-Hire-of-Aetherium-Medical-Platform.html
